Studies on Stibanate unresponsive isolates ofLeishmania donovani

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains of<i>Leishmania donovani</i>

Rosalía Lira, Shyam Sundar, Anand Makharia et al. · The Journal of Infectious Diseases · 1999 · 359 citations · Full text

In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis

F. Faraut-Gambarelli, Renaud Piarroux, M Deniau et al. · Antimicrobial Agents and Chemotherapy · 1997 · 201 citations · Full text

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first line drug? An observational study of 80 cases

C. P. THAKUR G. P. SINHA A. K. PANDEY · Annals of Tropical Medicine and Parasitology · 1998 · 104 citations

Translational Medicine, Ventricular Fibrillation, Antiparasitic Agent +8

Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study

C.P. Thakur, Manish Kumar, Puneet Kumar et al. · BMJ · 1988 · 104 citations · Full text

Activity of Antileishmanial Agents against Amastigotes in Human Monocyte-Derived Macrophages and in Mouse Peritoneal Macrophages

Jonathan Berman, Linda Lee · Journal of Parasitology · 1984 · 70 citations

Leishmania Multiplying, Parasitic Disease, Microbial Pathogens +23